Twin Tree Management
TEVA icon

Twin Tree Management’s Teva Pharmaceuticals TEVA Stock Holding History

Twin Tree Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,000
Closed -$162K – 1604
2021
Q1 		$162K Buy
+14,000
New +$161K ﹤0.01% 1153
2020
Q3 		– Sell
-1,250,700
Closed -$15.4M – 1572
2020
Q2 		$15.4M Buy
1,250,700
+631,500
+102% +$7.14M 0.06% 350
2020
Q1 		$5.56M Buy
619,200
+605,100
+4,291% +$6.2M 0.03% 462
2019
Q4 		$138K Buy
+14,100
New +$126K ﹤0.01% 1054
2019
Q3 		– Sell
-820,800
Closed -$7.58M – 1513
2019
Q2 		$7.58M Sell
820,800
-699,100
-46% -$8.43M 0.04% 353
2019
Q1 		$23.8M Sell
1,519,900
-389,600
-20% -$6.87M 0.12% 145
2018
Q4 		$29.4M Buy
1,909,500
+1,118,100
+141% +$22.9M 0.18% 95
2018
Q3 		$17M Sell
791,400
-288,100
-27% -$6.69M 0.12% 159
2018
Q2 		$26.3M Sell
1,079,500
-130,700
-11% -$2.67M 0.16% 113
2018
Q1 		$20.7M Buy
1,210,200
+204,500
+20% +$3.99M 0.17% 103
2017
Q4 		$19.1M Buy
1,005,700
+974,800
+3,155% +$14.7M 0.14% 123
2017
Q3 		$544K Sell
30,900
-21,000
-40% -$473K ﹤0.01% 754
2017
Q2 		$1.72M Sell
51,900
-367,400
-88% -$11.4M 0.01% 582
2017
Q1 		$13.5M Buy
+419,300
New +$14.3M 0.12% 166
2016
Q3 		– Sell
-24,400
Closed -$1.23M – 1333
2016
Q2 		$1.23M Buy
+24,400
New +$1.3M 0.02% 603
2016
Q1 		– Sell
-64,500
Closed -$4.23M – 1491
2015
Q4 		$4.23M Buy
64,500
+49,700
+336% +$3.07M 0.08% 233
2015
Q3 		$836K Sell
14,800
-1,000
-6% -$64.8K 0.02% 601
2015
Q2 		$934K Sell
15,800
-5,000
-24% -$308K 0.02% 653
2015
Q1 		$1.3M Sell
20,800
-7,300
-26% -$424K 0.03% 517
2014
Q4 		$1.62M Sell
28,100
-11,300
-29% -$630K 0.05% 447
2014
Q3 		$2.12M Sell
39,400
-17,600
-31% -$932K 0.06% 365
2014
Q2 		$2.99M Sell
57,000
-114,700
-67% -$5.86M 0.07% 306
2014
Q1 		$9.07M Buy
171,700
+123,900
+259% +$5.73M 0.18% 100
2013
Q4 		$1.92M Buy
47,800
+24,200
+103% +$953K 0.05% 414
2013
Q3 		$892K Sell
23,600
-1,000
-4% -$39K 0.03% 498
2013
Q2 		$964K Buy
+24,600
New +$958K 0.04% 482

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Twin Tree Management's TEVA Position: Q2 2023 in Review

Twin Tree Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 2,141 shares — an estimated $18.9K sold.

Twin Tree Management first reported a position in TEVA in Q2 2013 and held it in 31 quarters. The position peaked at $11.4M in Q1 2017. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Twin Tree Management reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Twin Tree Management sold 2,141 Teva Pharmaceuticals shares in Q2 2023, an estimated $18.9K.
  • Twin Tree Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Twin Tree Management's Teva Pharmaceuticals position peaked at $11.4M in Q1 2017.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Twin Tree Management's 13F filing for Q2 2023, filed 11 Aug 2023.